SEC 13F Intelligence

Altium Capital Management LLC / ARQT

Altium Capital Management LLC’s Arcutis Biotherapeutics Inc Position

Does Altium Capital Management LLC own Arcutis Biotherapeutics Inc (ARQT)? Not currently — the last reported position was 255.0K shares worth $6M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$6M
Q3 2021
Shares
255.0K
% of Portfolio
+1.60%
Quarters Held
4
position exited

Position History ARQT

Reported value by quarter
Q4 ’20: $2MQ4 ’20Q1 ’21: $3MQ1 ’21Q2 ’21: $6MQ2 ’21Q3 ’21: $6MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021255.0K$6M+1.60%
Q2 2021231.3K$6M+1.46%
Q1 2021114.0K$3M+0.92%
Q4 202063.0K$2M+0.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of ARQT.